FDG/PET-based Cancer Treatment Response Assessment

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Nov. 28, 8:30-10:00 a.m. | S504CD

This session examines important PET/CT findings using FDG and other tracers. Participants also learn how to avoid potential pitfalls, use PET tracers to evaluate tumor response and compare available tracer options for evaluating treatment response.

Speaker Information:

•             Lale Kostakoglu, MD, Mount Sinai Hospital, New York City

•             Heather Jacene, MD, Children’s Hospital Boston

•             Terence Zekon Wong, MD, PhD, Duke University, Durham, N.C.